Corticosteroid inhaler names

Your Nasacort ® Nasal Inhaler should be cleaned weekly. Remove the white protective cap from nasal inhaler. Remove the canister from the nasal inhaler. Clean the nasal inhaler thoroughly in lukewarm water. The use of soap, detergent, or disinfectant is not necessary. Allow the inhaler to dry completely. Gently center and insert the canister with the plastic stem downward into the small hole at the bottom of the nasal inhaler. Replace the white protective cap on nasal inhaler. The canister should be discarded after 100 actuations. The canister and nose piece are designed to be used together. Never use this canister or nose piece with those from any other product.

Report an adverse event

  • Advertising
  • Privacy
  • Careers at Haymarket
  • Help
  • Terms and Conditions
  • Contact us
  • Editorial Complaint
  • Sign out
  • My Account
  • Subscribe
  • About us
  • FAQs
  • MIMS Adviser
  • GPonline
  • MIMS Learning
  • Medeconomics
© Haymarket Media Group Ltd.

Report an adverse event

  • Advertising
  • Privacy
  • Careers at Haymarket
  • Help
  • Terms and Conditions
  • Contact us
  • Editorial Complaint
  • Sign in
  • Register
  • Subscribe
  • About us
  • FAQs
  • MIMS Adviser
  • GPonline
  • MIMS Learning
  • Medeconomics
© Haymarket Media Group Ltd.

The growth of children and adolescents receiving orally inhaled corticosteroids, including QVAR, should be monitored routinely (., via stadiometry). If a child or adolescent on any corticosteroid appears to have growth suppression, the possibility that he/she is particularly sensitive to this effect should be considered. The potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the risks associated with alternative therapies. To minimize the systemic effects of orally inhaled corticosteroids, including QVAR, each patient should be titrated to his/her lowest effective dose [see Dosage and Administration ( )] .

Corticosteroid inhaler names

corticosteroid inhaler names

The growth of children and adolescents receiving orally inhaled corticosteroids, including QVAR, should be monitored routinely (., via stadiometry). If a child or adolescent on any corticosteroid appears to have growth suppression, the possibility that he/she is particularly sensitive to this effect should be considered. The potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the risks associated with alternative therapies. To minimize the systemic effects of orally inhaled corticosteroids, including QVAR, each patient should be titrated to his/her lowest effective dose [see Dosage and Administration ( )] .

Media:

corticosteroid inhaler namescorticosteroid inhaler namescorticosteroid inhaler namescorticosteroid inhaler namescorticosteroid inhaler names